Literature DB >> 26827720

The inactivation of extracellular signal-regulated kinase by glucagon-like peptide-1 contributes to neuroprotection against oxidative stress.

Shingo Nakajima1, Tadahiro Numakawa2, Naoki Adachi3, Hyung Shin Yoon4, Haruki Odaka5, Yoshiko Ooshima6, Hiroshi Kunugi4.   

Abstract

Glucagon-like peptide-1 (GLP-1), an insulinotropic peptide secreted from enteroendocrine cells, has been known to have a neuroprotective effect. However, it is not fully understood the intracellular mediator of GLP-1 signaling in neuronal cells. In the present study, we examined the change in intracellular signaling of cortical neurons after GLP-1 application and luminal glucose stimulation in vitro and in vivo. GLP-1 receptor was highly expressed in cultured cortical neurons and brain tissues including the prefrontal cortex and hippocampus. The activation of GLP-1 receptor (5min) significantly decreased levels of phosphorylated extracellular signal-regulated kinase (pERK), which is involved in neuronal cell survival and death, in cultured cortical neurons. Oral glucose administration also rapidly reduced pERK levels in the prefrontal cortex, while intraperitoneal glucose injection did not show such an effect. Further, GLP-1 attenuated hydrogen peroxide-induced cell death and hyperactivity of ERK in cultured cortical neurons. It is possible that increased GLP-1 by luminal glucose stimulation affects cortical system including the maintenance of neuronal cell survival.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral cortex; Extracellular signal-regulated kinase; Glucagon-like peptide-1; Neuroprotection; Oral glucose

Mesh:

Substances:

Year:  2016        PMID: 26827720     DOI: 10.1016/j.neulet.2016.01.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  Exenatide reduces oxidative stress and cell death in testis in iron overload rat model.

Authors:  Suleyman Yesil; Nuran Sungu; Aydan Kilicarslan; Serife Mehlika Kuskonmaz; Halil Kara; Aysegul Kucuk; Fazli Polat; Mustafa Kavutcu; Mustafa Arslan
Journal:  Exp Ther Med       Date:  2018-09-26       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.